HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
Edward J. Jarman(Western General Hospital), Simon P. Langdon(MRC Institute of Genetics and Molecular Medicine)
Cited by 69
Related Papers
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
|BMC Cancer|2018|107
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of<i>in vitro</i>breast cancer models
|Oncotarget|2015|96
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling
|Molecular Cancer Therapeutics|2007|55
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
|British Journal of Cancer|2012|49